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Abstract
Recent work has demonstrated that Drosophila can be used as a model of dilated cardiomyopathy, defined as an enlarged
cardiac chamber at end-diastole when the heart is fully relaxed and having an impaired systolic function when the heart is
fully contracted. Gene mutations that cause cardiac dysfunction in adult Drosophila can result from abnormalities in cardiac
development or alterations in post-developmental heart function. To clarify the contribution of transgene expression to
post-developmental cardiac abnormalities, we applied strategies to examine the temporal and spacial effects of transgene
expression on cardiac function. We engineered transgenic Drosophila based on the well-characterized temperature-sensitive
Gal80 protein in the context of the bipartite Gal4/UAS transgenic expression system in Drosophila employing the cardiac
specific driver, tinCD4-Gal4. Then, we developed a strategy using optical coherence tomography to serially measure cardiac
function in the individual flies over time course of several days. As a proof of concept we examined the effects of the
expression of a human mutant delta-sarcoglycan associated with familial heart failure and observed a reversible, post-
developmental dilated cardiomyopathy in Drosophila. Our results show that the unique imaging strategy based on the non-
destructive, non-invasive properties of optical coherence tomography can be applied to serially examine cardiac function in
individual adult flies. Furthermore, the induction and reversal of cardiac transgene expression can be investigated in adult
flies thereby providing insight into the post-developmental effects of transgene expression.
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Introduction
The identification of genes that cause or modify cardiac
function is important in understanding the complex biology that
is responsible for dilated cardiomyopathy and heart failure in
humans. Recent work has demonstrated that Drosophila can be
used as a model of cardiovascular disease.[1,2,3,4] We have
developed a strategy using optical coherence tomography (OCT)
imaging in awake, adult Drosophila to identify genes that cause
dilated cardiomyopathy, defined as an enlarged cardiac chamber
at end-diastole when the heart is fully relaxed and impaired
systolic function when the heart is fully contracted.[4] Optical
coherence tomography (OCT) is based on reflectivity of near-
infrared light and provides functional image information of the
adult fly heart in a manner similar to echocardiography in
humans.[4,5] Although OCT has limited spacial resolution and
the evaluation of the adult Drosophila cardiac chambers is limited to
the conical chambers located in the A1–A2 segments, OCT
imaging is well-suited as a strategy to systematically evaluate the
impact that gene mutations have on the development of dilated
cardiomyopathy in the adult fly.
Since the cardiac abnormalities associated with mutations or
transgene expression can result from alterations in embryonic
dorsal vessel development or manifest later in the mature adult
heart, we sought to develop a strategy to examine post-
developmental temporal effects of cardiac-specific transgene
expression. To test this strategy, we examined a human mutation
in delta-sarcoglycan (SGCD) as a proof-of-concept.
We previously demonstrated that the expression of human
mutation in SGCD with a serine to alanine mutation at amino
acid position 151 (S151A) previously associated with human
familial dilated cardiomyopathy results in the dilated cardiomy-
opathy in awake, adult flies whereas the human wild-type SGCD
does not affect Drosophila cardiac function [4,6]. The expression of
the SGCD transgenes were under the control of tinCD4-Gal4 that
is driven in Drosophila cardioblasts from early dorsal vessel
development and through adulthood [7]. This observation raised
the question regarding the temporal relationship between mutant
transgene expression and the cardiac dysfunction that was
observed in the adult fly. We used a set of transgenic Drosophila
based on the well-characterized temperature-sensitive Gal80
protein (Gal80
ts) in the context of the bipartite Gal4/UAS
transgenic expression system in Drosophila employing the cardiac
specific driver, tinCD4-Gal4. [7,8,9,10,11,12] Then, we modified
our use of OCT in a unique manner to perform a serial evaluation
of the cardiac function in individual awake, adult Drosophila of the
course of several days.
Results
To test whether post-developmental, cardiac expression of
transgenes can cause dilated cardiomyopathy, we engineered a
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transgenes based on the p{tub-Gal80
ts} system described by
McGuire et. al. that examined Drosophila transgene expression in
the nervous system.[9,10] We then examined the post-develop-
mental effects of a mutant S151A-human-SGCD that has been
previously shown to cause dilated cardiomyopathy in Drosophila.
We examined p{tub-Gal80
ts}; p{tinCD4-Gal4} flies that harbored
either p{UAS-wt-human-SGCD} or p{UAS-S151A-human-
SGCD}. Since the context of the genetic background is known
to influence the phenotypic expression of traits, we used double
homozygous p{tub-Gal80
ts}; p{tinCD4-Gal4} as a stock and then
crossed in specific UAS-transgenes that were engineered in a w
1118
background. We examined the F1 flies from these crosses so that
the genetic backgrounds were similar between groups for all
investigations. As a control, we examined the cardiac function in
the double homozygous p{tub-Gal80
ts}; p{tinCD4-Gal4} driver
line and determined that the cardiac parameters measured by
OCT were similar to w
1118 and Oregon-R (Table 1). Additionally,
we previously demonstrated that the effect of UAS-human SGCD
was independent of the transgene insertion location within the
genome since multiple insertion lines had similar effects on cardiac
function[4]. Furthermore, since individual flies were examined in a
serial manner, each baseline cardiac assessment served as a control
for subsequent measurements.
In our experiments, the Gal80
ts protein is functional at 18uC
and binds to Gal4 thereby preventing the interaction between
Gal4 and the UAS promoter so that the expression of the human-
SGCD transgene is repressed. However, at 26uC, Gal80
ts
dissociates from Gal4 thereby allowing Gal4 to bind to the UAS
promoter thereby resulting in human-SGCD transgene expres-
sion. Flies were maintained at 18uC until 7 days after eclosion and
then baseline cardiac function was examined by OCT. OCT
provides detailed measurement of heart rate, end-diastolic
dimension (EDD), end-systolic dimension (ESD), and fractional
shortening (FS), a surrogate measurement of contractility. Since
OCT is non-destructive and non-invasive, we recovered each fly
after image acquisition and repeated serial assessments of cardiac
function. The flies were maintained at 26uC and cardiac function
in individual flies was serially re-examined at 24, 48, and 96 hours
after baseline cardiac assessment. Then, the flies were returned to
18uC and cardiac function was serially examined at 120 and
168 hours after baseline cardiac assessment. During the same time
course, parallel groups of flies were used to examine human-
SGCD transgene expression using QRT-PCR.
The expression of wt-human-SGCD had no significant effect on
cardiac function since the cardiac parameters remained stable
throughout the experiments in the F1 offspring from a cross
between p{tub-Gal80
ts}; p{tinCD4-Gal4} flies and flies that
harbored p{UAS-wt-human-SGCD} (Figure 1). Fractional short-
ening was 99+/21% in flies harboring p{UAS-wt-human-
SGCD} at 18uC and 96+/22% at 26uC for 96 hours.
Additionally, the cardiac function at 18uC in the F1 offspring
from a cross between p{tub-Gal80
ts}; p{tinCD4-Gal4} flies and
flies that harbored either p{UAS-wt-human-SGCD} or p{UAS-
S151A-human-SGCD} was similar to the common laboratory
stock, w
1118 and Oregon-R (Table 1).
Interestingly, the F1 offspring from a cross between p{tub-
Gal80
ts}; p{tinCD4-Gal4} flies and flies that harbored p{UAS-
S151A-human-SGCD} demonstrated a progressivedeteriorationin
cardiac function manifest as an increase in ESD and EDD with a
resultant decrease FS. By 96 hours, FS decreased from 97+/21%
to 69+/23%; p,0.05 (Figure 1). The changes in cardiac function
paralleled increases in human-SGCD transgene expression but
were delayed by about 24 hours after the induction of transgene
expression as determined by QRT-PCR of human SGCD
(Figure 2). Moreover, a temperature shift from 26uCt o1 8 uC
resulted in a significant reduction in SGCD transgene expression to
baseline levels and concomitant improvement in cardiac function
with a restoration of ESD, EDD, and FS to baseline values in the
S151A- SGCD group. Again, the improvement in cardiac function
paralleled the reduction in transgene expression with functional
changes lagging transgene expression changes by about 24 hours as
determined by QRT-PCR (Figure 2).
Discussion
Our results demonstrate that serial cardiac measurements can
be easily obtained in adult Drosophila and that we can examine the
post-developmental effects of transgene expression and repression
on cardiac function. To date, the assessment of cardiac function in
adult flies has mostly relied on an examination of partially
dissected specimens that are perfused in a temperature-controlled
artificial hemolymph solution.[1,13,14] While this approach
provides valuable information about cardiac function, the analysis
of a partially dissected preparation is confined to several hours
until the specimen deteriorates. Thus, an approach that is based
on the examination of dissected heart preparations precludes
a serial examination of the same fly over an extended period of
time.
For the first time, we demonstrate that our non-invasive
imaging strategy has the advantage of examining cardiac function
over the course of several days and possibly weeks. This provides
the possibility to serially examine age-related changes in cardiac
function in individual flies where each fly can be evaluated by
repeated measurements, a technique that is applicable to mouse
models of cardiac disease but thus far not available to fly models.
Additionally, our strategy is applicable to a variety of transgenes
Table 1. Cardiac parameters in w
1118, Oregon-R, and the cardiac-specific, inducible driver line.
N EDD (microns) ESD (microns) FS (%)
W
1118 11 70653 619 6 62
Oregon-R 11 75632 619 7 62
Gal80
ts;tinCD4-Gal4 driver line 12 76643 619 6 62
Gal80
ts; tinCD4-Gal4 harboring WT-SGCD 16 64621 619 9 61
Gal80
ts; tinCD4-Gal4 harboring S151A-SGCD 16 63642 619 7 61
OCT measurements of end diastolic dimension (EDD) in microns, end systolic dimension (ESD) in microns, and fractional shortening (FS) in percentage are expressed as
the mean +/2 SE. The values for w
1118 (n=11), Oregon-R (n=12), the homozygous Gal80
ts; tincD4-Gal4 driver line (n=11) were obtained from flies maintained at 26uC.
The values for the Gal80
ts; tincD4-Gal4 driver line harboring either wt-human-SGCD (n=16) or S151A-human-SGCD (n=16) were obtained from flies maintained at 18uC.
doi:10.1371/journal.pone.0007132.t001
Heart Failure in Flies
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gene. Furthermore, the cardiac effects of toxins, drugs, and other
environmental exposures can be examined using this strategy.
We chose to examine a mutant human-SGCD in our study as a
proof-of-concept to address the concept that post-developmental
cardiac abnormalities can result from the temporal regulation of
transgene expression. Interestingly, we not only observed that the
cardiac function in adult flies declined in response to the
expression of the mutant S151A-human-SGCD but that subse-
quent transgene repression resulted in an improvement in cardiac
function. Delta-sarcoglycan is a component of the dystrophin
glycoprotein complex located on the plasma membrane of skeletal
and cardiac myocytes.[15] The dystrophin glycoprotein complex
is required for normal muscle cell functions and is involved in the
transmission of signals from the extracellular matrix to the
contractile machinery within the cell. The S151A-human-SGCD
may act as a dominant negative isoform.[6] Accordingly, the
expression of the S151A-SGCD may disrupt or, at least, alter the
proper functioning of dystrophin glycoprotein complex thereby
inhibiting extracellular signals that are necessary to maintain
normal myocyte function. Conversely, the repression of S151A-
SGCD removes the dominant-negative effect and allows restora-
tion of the endogenous dystrophin glycoprotein complex. Inter-
estingly, we observed that the changes in cardiac function
occurred about 24 hours after transgene expression was induced
or repressed, a time course that appears consistent with transgene
protein production and incorporation into endogenous dystrophin
glycoprotein complex. While the exact mechanisms that are
responsible for the deterioration and subsequent improvement in
cardiac function are not known,mutations that disrupt the
Figure 1. Expression of human mutant S151A-SGCD causes an inducible and reversible dilated cardiomyopathy in adult Drosophila.
(A) Temperature shift from 18uCt o2 6 uC causes the induction of S151A-SGCD expression and subsequent deterioration in cardiac function. At
96 hours post induction, flies expressing S151A-SGCD demonstrate an enlargement in EDD and ESD with a resultant impairment in FS. At 96 hours, a
temperature shift back to 18uC results in a repression of S151A-SGCD expression and subsequent improvement in cardiac function with return of
EDD, ESD and FS to near baseline. A similar level of wt-SGCD expression after temperature shift from 18uCt o2 6 uC does not result in deterioration in
cardiac function. Each graph represents the summary data for serial OCT measurements of EDD, ESD and FS and are expressed as the mean +/2 SE
(n=16 for wt-SGCD and n=16 for S151A-SGCD). * P,0.05 for time point measurements compared to baseline and # P,0.05 for measurements
between wt-SGCD and S151A-SGCD at each time point. (B) Representative serial OCT m-modes in individual flies expressing S151A-SGCD or wt-SGCD
at the indicated times and temperatures. The arrows indicate EDD when the fly heart is fully relaxed and ESD when the fly heart if fully contracted. A
125 micron standard and 1 second scale bar is shown.
doi:10.1371/journal.pone.0007132.g001
Heart Failure in Flies
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opathies in flies and mammals[4,16,17].
Collectively, our results suggest that the combination of the
established power of the Gal80
ts system in conjunction with the
unique properties of OCT can provide a reliablestrategy to examine
the temporal effects of transgene expression on cardiac function in
the adult fly heart. We believe that the development of this
methodology should provide insight into signaling pathways that are
responsible for post-developmental cardiac dysfunction and may
lead to insights into reparative mechanisms for human heart failure.
Materials and Methods
Fly stocks
w[*]; P{tubP-GAL80[ts]}10; TM2/TM6B, Tb[1] was obtained
from the Bloomington Drosophila Stock Center. Transgenic
p{UAS-WT-human-SGCD} and p{UAS-S151A-human-SGCD}
flies were engineered in w1118 as previously described[4]. We
obtained two transgenic lines for p{UAS-WT-human-SGCD} and
three transgenic lines for p{UAS-S151A-human-SGCD}. In our
experiments, we used stocks for each transgene that demonstrated
similar levels of transgene expression at baseline. The p{tincD4-
gal4} fly line was generated in a yw background and kindly proved
by Manfred Frasch[12]. For all experiments, we examined the F1
offspring of crosses between the double homozygous P{tubP-
GAL80[ts]}10; p{tincD4-gal4} and either p{UAS-WT-human-
SGCD} or p{UAS-S151A-human-SGCD}. All fly stocks were
maintained on standard yeast protein, carbohydrate, agar media
at the indicated temperatures (18uCo r2 6 uC) according to
standard procedures.
Cardiac measurements in adult Drosophila
Cardiac function in adult Drosophila was measured using a
custom built OCT microscopy system (Bioptigen, Inc) as
previously described.[4] Briefly, adult Drosophila at 7 days post
eclosion were briefly subjected to CO2, placed on a soft gel
support, and allowed to fully awaken based on body movement.
Multiple OCT m-modes of heart function from awake Drosophila
were recorded along with a 125 micron standard. All images were
Figure 2. Expression of S151A-SGCD precedes cardiac function changes in adult Drosophila expressing S151A-SGCD. (A).Temperature
shift from 18uCt o2 6 uC results in deterioration in cardiac function and induction of S151A-SGCD expression. After a temperature shift to 26uC, the
induction of transgene expression precedes the development of dilated cardiomyopathy by 48 hours as demonstrated by QRT-PCR measurements of
S151A-SGCD mRNA levels compared to cardiac function by serial OCT. A second temperature shift back to 18uC represses S151A-SGCD mRNA
expression and results in restoration of cardiac function by 48 hours. We performed three independent experiments using different batches of flies
each time. The summary data for QRT-PCR at the indicated times and temperatures are expressed as the mean +/2 SE of three independent
experiments, each performed in triplicate. * p,0.05 for S151A-SGCD expression at indicted time vs. baseline; # p,0.05 for wt-SGCD expression at the
indicated time points vs. baseline; D p,0.05 for wt-SGCD vs. S151A-SGCD at the 48 hour time point. (B–D) Summary data for the time course of
S151A-SGCD expression (closed circles) vs. cardiac measurements (closed squares) based on serial measurements of EDD, ESD, and FS as described in
Figure 1.
doi:10.1371/journal.pone.0007132.g002
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processed using ImageJ software. End-diastolic (EDD), end-systolic
(ESD), and heart rate were determined from 3 consecutive heart
beats. Fractional shortening (FS) was calculated as [EDD-ESD]/
EDD x 100. All OCT imaging was conducted at room
temperature and flies were immediately returned to the designated
experimental temperatures after imaging.
For serial OCT studies, adult flies were bred at 18uC until 7
days post eclosion and baseline cardiac measurements were
obtained using OCT. Each fly was gently removed from the soft
gel support and placed in individual vials and maintained at 26uC.
Cardiac function in each individual fly was repetitively measured
at 24, 48, and 96 hours. Then, flies were returned to 18uC and
cardiac function was imaged at 120 and 168 hours after baseline
cardiac assessment.
QRT-PCR
Total RNA from thirty flies at each of the indicated times and
temperatures was prepared using RNA-Bee (Tel-Test ‘‘B,’’ Inc.,
Friendswood, TX) and treated with RNase-free DNaseI to remove
genomic DNA. cDNA was synthesized using invitrogen (Carlsbad,
CA) SuperScript II reverse transcriptase. Applied Biosystems
Taqman Gene expression assays were used to perform quantitative
(real time) RT-PCR (human delta-sarcoglycan, Hs01087180_m1
and fly ribosomal protein L32, Dm02151827_g1 for endogenous
control). The following reaction components were used for each
probe: 2 uL cDNA, 12.5 ul 2X TaqMan Universal PCRMaster
Mix (Applied Biosystems, Foster City, CA), 1.25 ul of either
Hs01087180_m1orDm02151827_g1probe,and 9.25 ul waterina
25 mL total volume. Reactions were amplified and analyzed in
triplicate using an ABI PRISMH 7000 Sequence Detection System.
PCR reaction conditions were as follows: Step 1: 50uC for 2
minutes, Step 2: 95uC for 10 minutes, Step 3: 40 cycles of 95uC for
15 seconds followed by 60uC for 1 minute. Expression relative to
ribosomal protein L32 was calculated using 2
2DDCt and levels were
normalized to baseline. We performed three independent experi-
ments in triplicate using different batches of flies each time.
Statistical Analysis
Statistical analysis was performed using GraphPad. Analyses of
variance (ANOVA) were performed using Bonferroni corrections
for multiple comparisons.
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